Parkinson's disease and ADHD are genetically linked, finds a brain study that could provide a roadmap for future treatment.
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
New biomarker tests could improve diagnostic accuracy in early Parkinson’s disease and even diagnose it before symptoms begin ...
A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
In his best game of the season -- Week 5 versus the Green Bay Packers -- Colby Parkinson finished with 5.2 fantasy points.
AbbVie has finally won Food and Drug Administration approval of its Vyalev therapy for patients with advanced Parkinson's disease. AbbVie on Thursday said the FDA green light makes Vyalev the first ...